For the Inventor, By the Inventor

Enter inventor name

New South Wales, Australia

Jonathan Morris

USPTO Granted Patents = 9 (Patent Applications = 1)

EPO Patents = 4 (Patent Applications = 1)

Average Co-Inventor Count = 2.7

ph-index = 2

Forward Citations = 11(Granted Patents)

Location History:

New South Wales, AU (2017 - 2019)
Sydney, AU (2020 - 2024)

Company Filing History:

Newsouth Innovations Pty Limited

University of Nottingham

Exonate Limited

Metro International Biotech, LLC

where one patent can have more than one assignee

Years Active: 2017-2025

Loading Chart...

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12325704 - SRPK1 inhibitors (2025-06-10),

2. 12024504 - 1-methyl-1H-pyrazol-3-yl derivatives for use in the treatment of neovascular diseases (2024-07-02),

3. 11420969 - SRPK1 inhibitors (2022-08-23),

4. 11180521 - Nicotinamide riboside analogs, pharmaceutical compositions, and uses thereof (2021-11-23),

5. 10696661 - Compounds (2020-06-30),

6. 10301264 - Compounds useful for treating ocular neovasculan (2019-05-28),

7. 9932330 - Piperazine derivatives for treating disorders (2018-04-03),

8. 9796707 - Piperazine derivatives for treating disorders (2017-10-24),

9. 9695160 - Piperazine derivatives for treating disorders (2017-07-04),

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…